Patient ID,Sample ID,RUN,Sample Date,Reception date,Gender,Date of Birth,Diagnosis date,Country,Nationality,Ethnicity,City of resisdence,NHS number,HIV infection,Pipeline,Hospital Name,Initial Genotype,Genotype,Subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A, Genotyping NS5B,Drug,Manufacturer,Therapy Class,Regime,Treatment date
126,H210780309,NGS94_(repeat_Miseq_NGS93),2020-09-11,2020-09-17,Male,2050-09-18,1988-04-05,Korea,Korean,White,,,Yes,PHE HCV bioinformatics pipeline,The Royal London Hospital,,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,asunaprevir,BMS,NS3A/4A protease inhibitor ,,2019-05-05
126,H210780309,NGS93,2020-09-11,2020-09-17,Male,2050-09-18,1988-04-05,Korea,Korean,White,,,Yes,PHE HCV bioinformatics pipeline,The Royal London Hospital,,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,asunaprevir,BMS,NS3A/4A protease inhibitor ,,2019-05-05
160,H210900535,NGS95,2021-01-30,2021-02-05,Male,1989-11-11,2000-12-14,Ireland,Irish,White,London,,Yes,PHE HCV bioinformatics pipeline,Great Ormond Street Hospital for Children,Not available,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
161,H210900536,NGS95,2020-03-13,2020-03-19,Female,1971-11-17,1995-12-27,Ireland,Irish,White,,,Yes,PHE HCV bioinformatics pipeline,Morriston Hospital ,,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,,2020-09-08
188,H211060466,NGS95,2020-03-03,2020-03-09,Female,2062-03-10,1996-07-14,Ireland,Irish,White,,,Yes,PHE HCV bioinformatics pipeline,Nuffield Health Taunton Hospital,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,,2019-06-05
24,H210360996,NGS91,2021-01-31,2021-02-06,Other,2055-10-04,1996-07-27,,Others,White,London,4680,No,PHE HCV bioinformatics pipeline,St George's Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,1 tablet per day,2019-04-05
271,H211520427,NGS97,2019-04-15,2019-04-21,Male,2061-12-20,1996-12-12,Ireland,Irish,Not Stated,,,Yes,PHE HCV bioinformatics pipeline,Sheffield Teaching Hospital,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
3,H210180795,NGS91,2019-11-25,2019-12-01,,1984-03-12,1995-04-17,Italy,Italian,Black African,Brighton ,4659,Yes,PHE HCV bioinformatics pipeline,John Radcliffe Hospital,1a,Check genotyping results by genes: NULL 1a,,,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
3,H210180794,NGS91,2020-07-06,2020-07-12,,1984-03-12,1995-04-17,Italy,Italian,Black African,Brighton ,4659,Yes,PHE HCV bioinformatics pipeline,John Radcliffe Hospital,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
344,H211841102,NGS99,2019-04-24,2019-04-30,Other,2042-01-24,1998-03-21,Brazil,Brazilian,Asian,,,Yes,PHE HCV bioinformatics pipeline,Morriston Hospital ,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,asunaprevir,BMS,NS3A/4A protease inhibitor ,,1988-03-05
